Dana Investment Advisors, Inc. Pacira Bio Sciences, Inc. Transaction History

Dana Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $30,470 - $39,028	-1,100 Reduced 10.53%	9,345 $273,000
Q4 2023 Feb 07, 2024	SELL	$26.32 - $34.31 $13,160 - $17,155	-500 Reduced 4.57%	10,445 $352,000
Q2 2023 Aug 15, 2023	SELL	$36.12 - $47.5 $645,825 - $849,300	-17,880 Reduced 62.03%	10,945 $438,000
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $33,753 - $41,211	-950 Reduced 3.19%	28,825 $1.18 Million
Q4 2022 Feb 13, 2023	SELL	$38.19 - $57.45 $220,509 - $331,716	-5,774 Reduced 16.24%	29,775 $1.15 Million
Q3 2022 Nov 15, 2022	SELL	$51.24 - $58.89 $120,823 - $138,862	-2,358 Reduced 6.22%	35,549 $1.89 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $1.95 Million - $3.09 Million	37,907 New	37,907 $2.21 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.